Why is Mangalam Drugs falling/rising?

As of 17-Sep, Mangalam Drugs and Organics Ltd is currently priced at 75.00, reflecting a slight increase of 0.05 or 0.07%. The stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, the delivery volume has decreased by 28.32% compared to the 5-day average, suggesting a decline in investor participation. Over the past week, the stock has dropped by 2.41%, and it has experienced significant declines over longer periods, with a year-to-date decrease of 35.32% and a one-year decline of 45.65%. There are no positive or negative factors available to provide further context on the stock's recent movement.
In the broader market context, the stock's performance has been notably weaker compared to the benchmark Sensex, which has gained 1.56% over the past week. While the Sensex has shown a positive return of 2.60% over the past month, Mangalam Drugs has suffered a 10.30% decline in the same period. This stark contrast highlights the challenges faced by Mangalam Drugs in attracting investor interest and maintaining its market position amidst a generally positive market environment.